Your browser doesn't support javascript.
loading
End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA.
Kostakoglu, Lale; Martelli, Maurizio; Sehn, Laurie H; Belada, David; Carella, Angelo-Michele; Chua, Neil; Gonzalez-Barca, Eva; Hong, Xiaonan; Pinto, Antonio; Shi, Yuankai; Tatsumi, Yoichi; Knapp, Andrea; Mattiello, Federico; Nielsen, Tina; Sahin, Deniz; Sellam, Gila; Oestergaard, Mikkel Z; Vitolo, Umberto; Trnený, Marek.
Afiliación
  • Kostakoglu L; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA.
  • Martelli M; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Sehn LH; BC Cancer Center for Lymphoid Cancer and the University of British Columbia, Vancouver, BC, Canada.
  • Belada D; 4th Department of Internal Medicine-Hematology, Faculty of Medicine, Charles University, Hradec Králové, Czech Republic.
  • Carella AM; Hematology and Bone Marrow Transplantation Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.
  • Chua N; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
  • Gonzalez-Barca E; Institut Català d'Oncologia, Institut d'Investigació Biomédica de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
  • Hong X; Fudan University Shanghai Cancer Center, Shanghai, China.
  • Pinto A; Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy.
  • Shi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China.
  • Tatsumi Y; Kinki University Hospital, Osaka, Japan.
  • Knapp A; F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Mattiello F; F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Nielsen T; F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Sahin D; F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Sellam G; F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Oestergaard MZ; F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Vitolo U; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia, IRCCS, Turin, Italy; and.
  • Trnený M; 1st Department of Medicine, 1st Faculty of Medicine, Charles University General Hospital, Prague, Czech Republic.
Blood Adv ; 5(5): 1283-1290, 2021 03 09.
Article en En | MEDLINE | ID: mdl-33651099
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Tomografía Computarizada por Tomografía de Emisión de Positrones Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article País de afiliación: Ciudad del Vaticano
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Tomografía Computarizada por Tomografía de Emisión de Positrones Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article País de afiliación: Ciudad del Vaticano